Journals / Dahili ve Cerrahi Bilimler Yoğun Bakım Dergisi / 2015 / Cilt: 6 - Sayı: 1

The Effect of Stress Ulcer Prophylaxis on Ventilator-Associated Pneumonia Incidence in the Intensive Care Unit

Stres Ülser Profilaksinin Yoğun Bakım Ünitesindeki Ventilatör İlişkili Pnömoni İnsidansı Üzerine Etkisi

Pages
10–12
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The aim of this review is to evaluate the effect of stress ulcer prophylaxis on VAP incidence in the intensive care unit

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Ventilator-associated pneumonia (VAP) is one of the most common causes of nosocomial infections in the intensive care unit.
📊
Key Findings & Data:Mechanically ventilated patients are at risk for upper gastrointestinal (GI) bleeding.
💡
Conclusion & Impact:The aim of this review is to evaluate the effect of stress ulcer prophylaxis on VAP incidence in the intensive care unit
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Ventilator-associated pneumonia (VAP) is one of the most common causes of nosocomial infections in the intensive care unit. Mechanically ventilated patients are at risk for upper gastrointestinal (GI) bleeding. It has been shown in previous studies that acid suppression therapy used for GI prophylaxis may cause the development of bacterial pneumonia. The aim of this review is to evaluate the effect of stress ulcer prophylaxis on VAP incidence in the intensive care unit

Özet

Ventilatör ilişkili pnömoni (VİP), yoğun bakım ünitelerinde (YBÜ) en sık görülen nozokomiyal enfeksiyonlardan biridir. Mekanik ventilasyon desteğindeki hastalar üst gastrointestinal sistem (GİS) kanaması için risk altındadır. GİS profilaksisi için kullanılan asit supresyon tedavisinin bakteriyel pnömoni gelişmesine neden olabileceği daha önceki çalışmalarda gösterilmiştir. Bu derlemede amaç, yoğun bakım ünitesinde yapılan stres ülser profilaksinin VİP insidansı üzerine olan etkisinin incelenmesidir

🔖

Cite This Article

AYGENCEL, G., AYDOĞAN, B. B., GÖNDEREN, K., ZERMAN, A., TÜRKOĞLU, M. (2022). The Effect of Stress Ulcer Prophylaxis on Ventilator-Associated Pneumonia Incidence in the Intensive Care Unit. Dahili ve Cerrahi Bilimler Yoğun Bakım Dergisi, Cilt: 6 - Sayı: 1, 10–12. https://ajindex.com/articles/486588

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. Langer M, Cigada M, Mandelli M, et al. Early onset pneumonia: multicenter study in intensive care units. Intensive Care Med 1987;13:342-6. [CrossRef] Coffin SE, Klompas M, Classen D, et al. Strategies to prevent ventilator-asso- ciated pneumonia in acute care hospitals. Infect Control Hosp Epidemiol 2008;29:31-40. [CrossRef] Cook DJ, Walter SD, Cook RJ, et al. Incidence of and risk factors for ventila- tor-associated pneumonia in critically ill patients. Ann Intern Med 1998;129:433-40. [CrossRef] Kostadima E, Kaditis AG, Alexopoulos El, et al. Early gastrostomy reduces the rate of ventilator-associated pneumonia in stroke or head injury pati- ents. Eur Respir J 2005;26:106-11. [CrossRef] Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies. A consensus state- ment, American Thoracic Society, November 1995. Am J Respir Crit Care Med 1996;153:1711-25. [CrossRef] Cook DJ, Fuller HD, Guyatt GH, et al. Risk factors for gastrointestinal bleeding in critically ill patients: Canadian Critical Care Trials Group. N Engl J Med 1994;330:377-81. [CrossRef] Kantorova I, Svoboda P, Scheer P, et al. Stress ulcer prophylaxis in critically ill patients: A randomized controlled trial. Hepatogastroenterology 2004;51:757-61.
  2. Cook DJ, Griffith LE, Walter SD, et al. Canadian Critical Care Trials Group. The attributable mortality and length of intensive care unit stay of clinically important gastrointestinal bleeding in critically ill patients. Crit Care 2001;5:368-75. [CrossRef] Mutlu GM, Mutlu EA, Factor P. GI complications in patients receiving mecha- nical ventilation. Chest 2001;119:1222-41. [CrossRef] Ellison RT, Perez-Perez G, Welsh CH, et al. Risk factors for upper gastrointes- tinal bleeding in intensive care unit patients: role of Helicobacter pylori. Federal Hyperimmune Immunoglobulin Therapy Study Group. Crit Care Med 1996;24:1974-81. [CrossRef] ASHP Therapeutic Guidelines on Stress Ulcer Prophylaxis. ASHP Commission on Therapeutics and approved by the ASHP Board of Directors on November 14, 1998. Am J Health Syst Pharm 1999;56:347-79.
  3. Chiba N, De Gara CJ, Wilkinson JM, et al. Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: A meta-analysis. Gastroenterology 1997;112:1798-810. [CrossRef] Laine L, Ahnen D, McClain C, et al. Review article: Potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors. Aliments Pharmacol Ther